TIDMSBS

RNS Number : 5812B

Source BioScience PLC

17 June 2016

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                                    Source BioScience plc 
---------------------------------------------------------------------------------------------  ---------------------- 
 (b) Owner or controller of interests and short positions disclosed, if different from 1(a):    N/A 
  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), 
  settlor and beneficiaries must be named. 
---------------------------------------------------------------------------------------------  ---------------------- 
 (c) Name of offeror/offeree in relation to whose relevant securities this form relates:        Source BioScience plc 
  Use a separate form for each offeror/offeree 
---------------------------------------------------------------------------------------------  ---------------------- 
 (d) Is the discloser the offeror or the offeree?                                               Offeree 
---------------------------------------------------------------------------------------------  ---------------------- 
 (e) Date position held:                                                                        16 June 2016 
  The latest practicable date prior to the disclosure 
---------------------------------------------------------------------------------------------  ---------------------- 
 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect   N/A 
  of any other party to the offer? 
  If it is a cash offer or possible cash offer, state "N/A" 
---------------------------------------------------------------------------------------------  ---------------------- 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security: 
-----------------------------------------------------------------------------------  -------------------------------- 
                                                                                       Interests     Short positions 
-----------------------------------------------------------------------------------  ------------  ------------------ 
                                                                                      Number    %      Number      % 
-----------------------------------------------------------------------------------  --------      -------------  --- 
 (1) Relevant securities owned and/or controlled:                                       Nil     -       Nil        - 
-----------------------------------------------------------------------------------  --------      -------------  --- 
 (2) Cash-settled derivatives:                                                          Nil     -       Nil        - 
-----------------------------------------------------------------------------------  --------      -------------  --- 
 (3) Stock-settled derivatives (including options) and agreements to purchase/sell:     Nil     -       Nil        - 
-----------------------------------------------------------------------------------  --------      -------------  --- 
                                                                                        Nil     -       Nil        - 
   TOTAL: 
-----------------------------------------------------------------------------------  --------      -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists:    None 
----------------------------------------------------------------------------  ----- 
 Details, including nature of the rights concerned and relevant percentages:   None 
----------------------------------------------------------------------------  ----- 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe (including directors' and 
  other employee options) of any person acting in concert with the party to the offer making 
  the disclosure: 
---------------------------------------------------------------------------------------------- 
 
   3(a) Beneficial holdings of the Directors of Source BioScience plc in its Ordinary Shares 
    Director           Number of Ordinary    Percentage of 
                                   Shares     total issued 
                                             share capital 
                                                       (%) 
   -----------------  -------------------  --------------- 
    Laurie Turnbull             2,750,000             0.79 
    Dr Nick Ash                   500,000             0.14 
    Dr Nick Leaves              1,028,557             0.29 
   -----------------  -------------------  --------------- 
 
 
   3(b) Interests of the Directors in Source BioScience plc Ordinary Shares under the Source 
   BioScience Executive Share Option Scheme and the Source BioScience 2015 Long Term Incentive 
   Plan 
    Director             Maximum   Date of          First   Last exercisable     Option 
                          number     Grant    exercisable               date      price 
                     of Ordinary                     date                       (pence) 
                          Shares 
                         awarded 
   --------------  -------------  --------  -------------  -----------------  --------- 
    Laurie                          31 Mar         31 Mar             30 mar 
     Turnbull            500,000      2008           2011               2018      7.88p 
                                    26 Apr         26 Apr             25 Apr 
                         400,000      2010           2013               2020      8.25p 
   --------------  -------------  --------  -------------  -----------------  --------- 
    Dr Nick                         31 Mar         31 Mar             30 Mar 
     Ash                 500,000      2008           2011               2018      7.88p 
                                    31 Mar         31 Mar             30 Mar 
                         400,000      2009           2012               2019      4.63p 
                                    26 Apr         26 Apr             25 Apr 
                         400,000      2010           2013               2020      8.25p 
                                    27 Sep         27 Sep             26 Sep 
                         600,000      2013           2016               2023      9.38p 
                                    21 Oct         21 Oct             20 Oct 
                       1,500,000      2013           2016               2023      9.50p 
                                    21 Oct         21 Oct             20 Oct 
                       1,500,000      2013           2016               2023      9.50p 
                                    21 Oct         21 Oct             20 Oct 
                         500,000      2013           2017               2024      9.50p 
                       3,821,538    25 Jun         15 Mar             25 Jun        nil 
                                      2015           2019               2025 
   --------------  -------------  --------  -------------  -----------------  --------- 
    Dr Nick                         31 Mar         31 Mar             30 Mar 
     Leaves              200,000      2008           2011               2018      7.88p 
                                    31 Mar         31 Mar             30 Mar 
                         300,000      2009           2012               2019      4.63p 
                                    26 Apr         26 Apr             25 Apr 
                         300,000      2010           2013               2020      8.25p 
                                    24 Apr         24 Apr             23 Apr 
                         300,000      2011           2014               2021      6.25p 
                                    27 Sep         27 Sep             26 Sep 
                         400,000      2013           2016               2023      9.38p 
                                    21 Oct         21 Oct             20 Oct 
                       1,000,000      2013           2016               2023      9.50p 
                                    21 Oct         21 Oct             20 Oct 
                       1,600,000      2013           2016               2023      9.50p 
                                    21 Oct         21 Oct             20 Oct 
                         400,000      2013           2017               2024      9.50p 
                       3,108,462    25 Jun         15 Mar             25 Jun        nil 
                                      2015           2019               2025 
   --------------  -------------  --------  -------------  -----------------  --------- 
    Tim Metcalfe       2,769,231    25 Jun         15 Mar             25 Jun        nil 
                                      2015           2019               2025 
   --------------  -------------  --------  -------------  -----------------  --------- 
---------------------------------------------------------------------------------------------- 
 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
------------------------------------------------------------------------------------------------ 
 
   None 
------------------------------------------------------------------------------------------------ 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
---------------------------------------------------------------------------------------------- 
 
   None 
---------------------------------------------------------------------------------------------- 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
-------------------------------------  --- 
 Supplemental Form 8 (SBL)              NO 
-------------------------------------  --- 
 
 
 Date of disclosure:    17 June 2016 
---------------------  -------------------- 
 Contact name:          Dr Nick Ash 
---------------------  -------------------- 
 Telephone number:      +44 (0)115 973 9010 
---------------------  -------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

FEEUBVARNOANAAR

(END) Dow Jones Newswires

June 17, 2016 07:55 ET (11:55 GMT)

Source Bioscience (LSE:SBS)
Graphique Historique de l'Action
De Oct 2024 à Oct 2024 Plus de graphiques de la Bourse Source Bioscience
Source Bioscience (LSE:SBS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024 Plus de graphiques de la Bourse Source Bioscience